Annual Shareholders Equity
$1.24 B
+$286.86 M+30.08%
December 31, 2023
Summary
- As of February 22, 2025, PCVX annual stockholders equity is $1.24 billion, with the most recent change of +$286.86 million (+30.08%) on December 31, 2023.
- During the last 3 years, PCVX annual shareholders equity has risen by +$894.63 million (+258.68%).
- PCVX annual shareholders equity is now at all-time high.
Performance
PCVX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$3.42 B
+$1.43 B+72.07%
September 30, 2024
Summary
- As of February 22, 2025, PCVX quarterly stockholders equity is $3.42 billion, with the most recent change of +$1.43 billion (+72.07%) on September 30, 2024.
- Over the past year, PCVX quarterly shareholders equity has increased by +$2.01 billion (+143.64%).
- PCVX quarterly shareholders equity is now at all-time high.
Performance
PCVX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PCVX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.1% | +143.6% |
| 3 y3 years | +258.7% | +1017.0% |
| 5 y5 years | +2248.8% | - |
PCVX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +336.8% | at high | +1103.3% |
| 5 y | 5-year | at high | +1266.2% | at high | +3312.9% |
| alltime | all time | at high | +1266.2% | at high | +3312.9% |
Vaxcyte Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.42 B(+72.1%) |
| Jun 2024 | - | $1.99 B(+0.1%) |
| Mar 2024 | - | $1.98 B(+59.9%) |
| Dec 2023 | $1.24 B(+30.1%) | $1.24 B(-11.6%) |
| Sep 2023 | - | $1.40 B(-2.1%) |
| Jun 2023 | - | $1.43 B(+51.7%) |
| Mar 2023 | - | $944.77 M(-0.9%) |
| Dec 2022 | $953.61 M | $953.61 M(+165.4%) |
| Sep 2022 | - | $359.31 M(-2.0%) |
| Jun 2022 | - | $366.50 M(+1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $359.54 M(+26.6%) |
| Dec 2021 | $284.02 M(-17.9%) | $284.02 M(-7.2%) |
| Sep 2021 | - | $305.96 M(-3.5%) |
| Jun 2021 | - | $317.02 M(-3.0%) |
| Mar 2021 | - | $326.94 M(-5.5%) |
| Dec 2020 | $345.84 M(-425.1%) | $345.84 M(-5.0%) |
| Sep 2020 | - | $364.07 M(-5.0%) |
| Jun 2020 | - | $383.21 M(+178.0%) |
| Mar 2020 | - | $137.85 M(-229.6%) |
| Dec 2019 | -$106.37 M(+84.3%) | -$106.37 M |
| Dec 2018 | -$57.73 M | - |
FAQ
- What is Vaxcyte annual stockholders equity?
- What is the all time high annual shareholders equity for Vaxcyte?
- What is Vaxcyte annual shareholders equity year-on-year change?
- What is Vaxcyte quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Vaxcyte?
- What is Vaxcyte quarterly shareholders equity year-on-year change?
What is Vaxcyte annual stockholders equity?
The current annual shareholders equity of PCVX is $1.24 B
What is the all time high annual shareholders equity for Vaxcyte?
Vaxcyte all-time high annual stockholders equity is $1.24 B
What is Vaxcyte annual shareholders equity year-on-year change?
Over the past year, PCVX annual stockholders equity has changed by +$286.86 M (+30.08%)
What is Vaxcyte quarterly stockholders equity?
The current quarterly shareholders equity of PCVX is $3.42 B
What is the all time high quarterly shareholders equity for Vaxcyte?
Vaxcyte all-time high quarterly stockholders equity is $3.42 B
What is Vaxcyte quarterly shareholders equity year-on-year change?
Over the past year, PCVX quarterly stockholders equity has changed by +$2.01 B (+143.64%)